14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
CGNX vs VNT: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, Vontier Corporation (VNT) captures the overall head-to-head institutional edge over Cognex Corp (CGNX) on higher Unified Composite conviction (32.1/100 SELL vs. 59.5/100 HOLD) after splitting the core matrix 5–5 (led by Valuation Multiples), while CGNX wins 5–1 across the 6-pillar growth and valuation breakdown. CGNX trades at $48.06 (24.7x Forward P/E, 25.0% operating margin) versus VNT at $43.79 (11.2x Forward P/E, 19.8% operating margin).
Composite vs. Pillar Nuance: While CGNX currently prints a higher short-term Unified Composite Score (59.5/100 HOLD vs. VNT 32.1/100 SELL), VNT captures the overall institutional head-to-head verdict (5–5 matrix metrics and 1–5 across the 6 pillars) due to superior fundamental profitability (19.8% vs. 25.0% operating margin) and revenue trajectory (-2.1% vs. +13.2% YoY).
Technical & Structure Timing Caution: CGNX is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 35.9); meanwhile VNT trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 81.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CGNX vs VNT. Trailing 12-month operating profitability (CGNX 25.0% vs VNT 19.8%) and valuation multiples (CGNX 24.7x vs VNT 11.2x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Scientific & Technical Instruments value chain with $8.5B market capitalization and 25.0% operating margin.
OpEx & R&D Reinvestment44.7% of Rev ($503M)
90D Engineering Disclosures0 Published
VNT Moat ProfileScale & Operating Efficiency Moat
Scientific & Technical Instruments Operator
Competes within the Scientific & Technical Instruments value chain with $5.7B market capitalization and 19.8% operating margin.
OpEx & R&D Reinvestment27.5% of Rev ($839M)
90D Engineering Disclosures0 Published
Investor FAQ CGNX vs VNT Key Questions & Quantitative Answers
As of Nov 16, 2026, Vontier Corporation (VNT) captures the overall head-to-head institutional edge over Cognex Corp (CGNX) on higher Unified Composite conviction (32.1/100 SELL vs. 59.5/100 HOLD) after splitting the core matrix 5–5 (led by Valuation Multiples), while CGNX wins 5–1 across the 6-pillar growth and valuation breakdown. CGNX trades at $48.06 (24.7x Forward P/E, 25.0% operating margin) versus VNT at $43.79 (11.2x Forward P/E, 19.8% operating margin). Composite vs. Pillar Nuance: While CGNX currently prints a higher short-term Unified Composite Score (59.5/100 HOLD vs. VNT 32.1/100 SELL), VNT captures the overall institutional head-to-head verdict (5–5 matrix metrics and 1–5 across the 6 pillars) due to superior fundamental profitability (19.8% vs. 25.0% operating margin) and revenue trajectory (-2.1% vs. +13.2% YoY). Technical & Structure Timing Caution: CGNX is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 35.9); meanwhile VNT trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 81.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
CGNX leads the Growth & Scale pillar: CGNX posts +13.2% YoY revenue growth and +400.0% YoY earnings growth on $1.13B TTM revenue (69.7% gross margin, 25.0% operating margin), compared with VNT at -2.1% YoY revenue growth and +4.3% YoY earnings growth on $3.05B TTM revenue (47.3% gross margin, 19.8% operating margin). On trailing 12-month operating scale, CGNX generates $1.13B in USD-normalized revenue versus $3.05B for VNT. In operating R&D and SG&A reinvestment, CGNX deploys 44.7% of Rev ($503M) (0 90-day corporate R&D disclosures) versus 27.5% of Rev ($839M) (0 disclosures) for VNT.
VNT screens cheaper on headline valuation multiples. CGNX trades at 24.7x Forward P/E, 35.5x Trailing P/E, 2.71x PEG, and 7.0x EV/Revenue (25.4% FCF margin), whereas VNT trades at 11.2x Forward P/E, 17.7x Trailing P/E, 1.03x PEG, and 1.9x EV/Revenue (23.4% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CGNX (15.1% ROE) versus VNT (28.0% ROE) capital efficiency.
In options market volatility and institutional positioning, CGNX carries 53.5% implied volatility (16th %ile, Compressed (<25th %ile)), a 1.96x (Put-Skewed) Put/Call open-interest ratio, ACCUMULATION on-balance volume, and sits in a BREAKDOWN options structure phase (2.19β · 65% Vol realized risk). By comparison, VNT carries 23.0% implied volatility (<1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.63β · 34% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.